Thailand’s Tourism Authority concluded international creator journeys in Phuket and Phang-nga, showcasing Thailand’s surf and wellness experiences. This promotes “Healing Is the New Luxury” through Thailand Surf Therapy initiatives.

Thailand’s New Tourism Initiative

On 14 August 2026, Bangkok witnessed the conclusion of an innovative tourism initiative by the Tourism Authority of Thailand (TAT). The Amazing Thailand Surf & Wellness Journey and Amazing Thailand x Insta360 creator itinerary encompassed a unique blend of experiences in Phuket and Phang-nga. These journeys showcased Thailand’s surf, wellness, and cultural offerings, adhering to TAT’s “Healing Is the New Luxury” theme. Media representatives and global creators from diverse markets were immersed in activities promoting physical and mental well-being, spotlighting Thailand’s unique approach to meaningful travel.

Engaging with Wellness and Surf Therapy

In line with Thailand Health Excellence 2026, TAT’s new initiative incorporates Thailand Surf Therapy, utilizing international concepts from Waves for Change. This approach is structured as a wellness experience emphasizing surfing, mindfulness, and positive social connections rather than medical treatment. From 8–13 August, participants, including several international influencers, engaged in a series of activities, combining wellness at places like Devasom Khao Lak with adventure experiences like forest bathing, kayaking, and cultural tourism in Takua Pa.

Building Experiences for Global Markets

Participants actively contributed content across platforms, enhancing the international visibility of these wellness experiences and the Amazing Thailand brand. Simultaneously, the Insta360 partnership involved creators from different Asian countries in activities under the same wellness narrative. On 9 August, a networking dinner facilitated connections between participants and local tourism stakeholders. TAT aims to develop these experiences into market-ready products, highlighting Thailand’s increase in capacity for hosting wellness-focused tourism. This initiative underscores a shift towards tourism that enriches travelers through authentic, engaging experiences.

Source : TAT showcases Thailand Surf Therapy to global audiences under Healing Is the New Luxury

‘Select has been a trusted partner to Ramside for many years and already provides much of the Wi-Fi, networking and communications infrastructure’

The owner of some of the North East’s best known hotels and bars has snapped up a tech firm.

Hospitality group Ramside Estates – which operates Ramside Hall Hotel and Golf Club, Hardwick Hall, Bowburn Hall, The Fed and bars in Newcastle and Sedgefield – has consolidated its future growth plans with the acquisition of Select Telecom Limited.

Based in Brunswick Village, Newcastle, the firm been a long-standing supplier to Ramside, providing ongoing support across the group by providing Wi-Fi, connectivity and communications among other services.

The group says that reliable connectivity – including guest WiFi, operational systems, payment technology, hotel systems, events, conferences, offices and other digital services – is now fundamental to virtually every area of Ramside’s operations.

It says the acquisition of a company with which it already has a strong and established relationship, will not only protect Ramside’s critical infrastructure but also give the business greater control over its development, resilience and ongoing support.

Bosses said the deal also brings specialist expertise into the wider group, helping Ramside design technology and connectivity into developments from the start.

Select will continue to operate as a telecommunications business, serving its existing and future customers.

Martin Smith, head of finance at Ramside Estates Ltd, said: “Select has been a trusted partner to Ramside for many years and already provides much of the Wi-Fi, networking and communications infrastructure across our business.

“As our reliance on technology and connectivity continues to grow, particularly alongside the significant investment we are making across the Group, bringing that expertise closer to the business makes a great deal of strategic sense.

“What particularly attracted us to Select was that we already knew the business, the quality of its people and the service it provides.

“This acquisition isn’t simply about supporting Ramside, however. Select has a strong and established customer base of its own and we see a real opportunity to invest in the business, support the existing team and help Select continue to grow as part of the wider Ramside Group.”

Last month Ramside Estates published its accounts for the year ended November 2025, highlighting new leisure additions. Revenues rose to £37.4m – up by £300,000 on the previous year – while gross profit stood at £30.64m, up from £30.27m. Operating profit dropped from £2.44m to £1.88m, and pre-tax profit fell to £2.05m from £2.6m, a figure the firm said was primarily driven by higher golf course costs associated with new drainage and maintenance works.

The directors also highlighted new additions including the new leisure facility at Ramside Golf Club called The Pin, which it said “represents a strategic diversification of the group’s leisure offering”.

X Money, the financial arm of Elon Musk’s social media platform X, is pitching users a 6% annual yield on cash deposits, a rate significantly higher than what most traditional banks and even top-tier high-yield savings accounts currently offer, though the fine print behind the headline number has drawn scrutiny from at least one U.S. senator.

Launched in beta to select Premium+ subscribers in late June, X Money offers a 6% annual percentage yield on cash deposits with no stated minimum balance requirement, along with FDIC insurance protection. According to the app’s structure, standard deposits are held at Cross River Bank, a New Jersey-based, FDIC-member institution, providing the baseline $250,000 in federal deposit insurance coverage available to any standard bank account. For eligible Premium+ subscribers, X Money also offers an enhanced protection option through what the company calls its X Cash Sweep Program, which automatically distributes larger account balances across a network of partner banks, keeping each individual slice under the $250,000 insurance threshold to reach total aggregate coverage of up to $10 million, roughly 40 times the protection offered by a typical single bank account.

By comparison, the national average savings account rate currently sits at just 0.38%, according to the Federal Deposit Insurance Corporation, meaning $10,000 left in a typical savings account for a year would generate only about $38 in interest, roughly the cost of a single cup of coffee per month. Against that backdrop, X Money’s 6% headline rate represents a dramatic departure from what most consumers are accustomed to earning on idle cash.

Beyond the yield itself, X Money includes several other features positioning it as a broader alternative to traditional banking products. The service offers unlimited 3% cash back on eligible purchases made with a personalized, laser-engraved metal Visa debit card that can display a user’s X handle, along with no foreign transaction fees, free ATM withdrawals, peer-to-peer transfers to other X accounts, bill payment functionality, wire transfers and even check mailing directly from within the app. The service also supports early direct deposit, allowing paychecks to arrive up to two days ahead of a traditional payment schedule, and automatically routes all creator payouts earned on the X platform directly into users’ X Money accounts by default.

Benji Taylor, head of design at X and Musk’s artificial intelligence company xAI, confirmed in a video presentation that deposits would be held at Cross River Bank “and at other FDIC-insured institutions” as part of the sweep program structure. That kind of multi-bank sweep arrangement is not itself a new concept in banking; wealthy individuals and businesses have used similar structures for years to extend deposit insurance coverage beyond the standard $250,000 limit at any single institution. What distinguishes X Money’s approach is the scale at which the company is offering the enhanced protection to a broader base of subscribers, alongside a yield well above prevailing market rates.

The unusually high yield has attracted attention from federal lawmakers. Sen. Elizabeth Warren has raised questions about how Musk’s platform can sustainably offer a rate that no traditional bank in the country currently matches, according to reporting on the product’s rollout. Her inquiry reflects broader questions circulating among financial analysts and consumer advocates regarding the underlying economics of the offering, given that banks typically generate the revenue needed to pay depositor interest through lending activities, and it remains unclear precisely how X Money’s rate is being funded or how long the company intends to sustain it at current levels.

Regulatory attention extends beyond Warren’s individual inquiry. According to coverage of the product’s launch, the Consumer Financial Protection Bureau, the FDIC and various state regulators are already focused more broadly on so-called banking-as-a-service arrangements, sometimes referred to as “rent-a-charter” models, in which technology companies partner with FDIC-insured banks to offer bank-like products without becoming banks themselves. Regulators have also expressed concern in recent years about companies potentially misrepresenting the scope or nature of deposit insurance protections to consumers. Given those existing regulatory priorities, analysts have suggested X Money is likely to face close supervisory scrutiny even if no formal enforcement action has yet been initiated against the company.

It is important to note what the FDIC insurance attached to X Money deposits does and does not cover. The insurance protects depositors’ funds in the event that one of the partner banks holding their money fails, consistent with standard federal deposit insurance protections available at any FDIC-member institution. It does not, however, extend to X or X Money itself as a company, meaning the insurance framework applies specifically to the underlying banking partners rather than to Musk’s broader platform or business operations.

X Money’s launch represents the culmination of a payments initiative Musk has publicly discussed since rebranding Twitter as X, positioning the product as a potential challenger to both traditional megabanks such as JPMorgan Chase and Bank of America, as well as fintech competitors including SoFi Technologies and Robinhood Markets. The rollout has so far been limited to a controlled group of Premium+ subscribers, consistent with Musk’s history of gradually expanding new product access rather than launching features to the platform’s full user base immediately. Musk has previously indicated X Money could become more broadly available to the general public, though the exact timeline for a wider rollout has not been confirmed, and Musk has a well-documented history of announcing product timelines that ultimately extend well beyond his initial projections, a pattern some observers have referred to as operating on “Elon Time.”

For consumers considering the product, financial commentators have generally advised treating the offering with the same scrutiny applied to any high-yield financial product promising returns well above prevailing market rates, particularly given the outstanding questions regulators and lawmakers have raised regarding the sustainability of the 6% rate and the broader regulatory framework governing how technology companies operate bank-like financial products in partnership with traditional chartered institutions. As X Money continues its phased rollout, further regulatory scrutiny and potential responses from Warren’s office or federal banking regulators are likely to shape how the product evolves and whether its current rate structure proves durable over the longer term.

‘We’ve seen significant demand from customers across the region so having our own depot here strengthens our national network’

Growing North East shipping container business Cleveland Group has expanded with the opening of a new depot in South Yorkshire.

Cleveland Group – winner of Company of the Year at the North East Business Awards in 2022 – has continued its rapid national expansion with the opening of a new depot in Doncaster, to boost its ability to serve clients across South Yorkshire and the wider Yorkshire region.

Based in Stockton-on-Tees, the group comprises Cleveland Containers, Cleveland Modular and Cleveland Hire. It provides UK customers with shipping containers, modular buildings, site accommodation, and conversion solutions.

The Doncaster opening follows the opening of a new five acre depot in Newport, South Wales, last year, and builds on its existing Cleveland-operated locations in Newport, Middlesbrough, Ashby de la Zouch and Cambuslang. The day after its North East Business Awards win in September 2022 the business announced it had sealed a minority investment from private equity firm LDC to help steer the firm through the next stage of its growth.

Since then, the company has continued growing, more than doubling its workforce from 45 to 118. The company decided to open in Doncaster after analysing its existing customer base and delivery activity, and that area came up as a key location within its growing footprint.

Andrew Thompson, CEO at Cleveland Group, said: “Doncaster was a natural choice for Cleveland. We’ve seen significant demand from customers across the region, so having our own depot here strengthens our national network and puts us closer to the customers we serve. It’s another step forward for the business and an investment in delivering an even better customer experience.”

Six jobs have already been created at the new site, and further job opportunities are expected as the depot grows. The site will be led by newly appointed depot manager Darren Dunnill, who has overseen its development.

The new depot will provide additional capacity across Cleveland’s divisions, with a particular focus on supporting the construction and infrastructure sectors across Yorkshire. The site will predominantly provide site accommodation and modular buildings, supporting customers ranging from construction companies and housebuilders to schools, hospitals and emergency services.

Laura Moore, group operations director at Cleveland Group, added: “Investment in our infrastructure goes hand in hand with investment in our people. As we open new depots and expand the business, we’re creating opportunities for people to come into Cleveland, develop their skills and progress through the business.

“We want to give people with the right attitude and commitment the opportunity to build a long-term career with us.”

Shares of Moderna soared as much as 90% in premarket trading Wednesday, pacing what would become the biotech company’s best trading session on record, after the company and partner Merck announced that their experimental personalized mRNA cancer vaccine succeeded in a large, late-stage clinical trial for melanoma.

The Phase 3 trial, known as INTerpath-001, evaluated the treatment, called intismeran autogene, in combination with Merck’s blockbuster immunotherapy Keytruda, compared with Keytruda alone, in patients with completely surgically removed stage IIB-IV melanoma. The study enrolled 1,137 high-risk patients who received up to nine doses of the combination therapy over roughly one year. The trial met its primary goal of significantly extending the time patients lived without their melanoma returning, compared with Keytruda alone, and also achieved a key secondary goal of reducing the risk of the cancer spreading to distant parts of the body.

According to CNBC, the trial marked the first Phase 3 study to demonstrate clinically significant benefits over Keytruda monotherapy in the adjuvant treatment setting for surgically resected melanoma patients who had not previously received systemic cancer treatment. The companies said the study was stopped early at its first interim analysis after the positive results became apparent, and that no new safety signals had emerged during the trial. Side effects associated with the vaccine were described as similar to those typically experienced with other common vaccines.

Merck’s Dr. Jane Healy, the company’s head of oncology early development, described the significance of the results in comments to CNBC. Melanoma patients are “stuck having to deal with the new gravity of that diagnosis and then undergo uncomfortable treatments like surgery, and after that, they’re worried about their cancer coming back,” Healy said. She called the trial’s outcome “very exciting,” noting the therapy delivered a “clinically meaningful improvement” over Keytruda, which currently represents the standard of care for melanoma treatment. Healy added that the results also validate a personalized cancer treatment approach that Merck and Moderna have been developing for decades.

The intismeran vaccine represents a significant departure from Moderna’s earlier, pandemic-driven business, built instead on individualized cancer therapeutics tailored to each patient’s specific tumor. The treatment is manufactured for each patient based on mutations identified in that individual’s own tumor tissue, encoding as many as 34 distinct neoantigens designed to train the patient’s immune system to recognize and attack cancer cells bearing those same mutations. Moderna has said it has successfully automated the personalized manufacturing process required to produce each patient-specific dose.

Wednesday’s data builds on earlier, smaller-scale results the companies presented in January from a mid-stage trial of the same treatment combination. That earlier Phase 2b study found that at 60.3 months of follow-up, the combination therapy reduced the risk of cancer recurrence or death by 49%, while reducing the risk of distant metastasis or death by 59%, compared with Keytruda alone. Moderna’s chief development officer, David Berman, said those earlier durability findings supported the treatment’s “potential long-term benefit,” a framing that added weight to investor expectations heading into Wednesday’s larger, confirmatory Phase 3 readout.

Despite the strength of Wednesday’s results, some key data points remain outstanding. According to reporting on the trial, the companies have not yet disclosed specific hazard ratios or mature overall survival data, and the trial itself remains ongoing, with overall survival tracked as a key secondary endpoint still to be determined as follow-up continues. The companies said they plan to present the full results at an upcoming medical conference and share the data with regulators as part of the broader review and potential approval process.

Market reaction to the news was dramatic and immediate. Moderna shares surged as much as 90%, according to CNBC, touching levels not seen in months, while Merck shares climbed more than 8% in premarket trading. The disparity in the two companies’ stock reactions reflects their significant difference in size: Merck entered Wednesday with a market capitalization of roughly $333 billion, while Moderna’s stood at approximately $25 billion, meaning the same positive trial news carried far greater proportional significance for Moderna’s smaller balance sheet and narrower product pipeline.

According to Bloomberg, Moderna’s stock had already climbed 113% from the start of the year through Tuesday’s close, driven substantially by anticipation surrounding the cancer vaccine program even before Wednesday’s formal trial results were announced. Wall Street analyst reaction to the news was swift, with the stock’s move clearing every existing price target among the roughly 15 analysts tracking the company, according to one market analysis, even as several firms had maintained more cautious ratings on the stock ahead of the announcement.

Analysts have pointed to the substantial commercial potential the therapy could represent if it ultimately receives regulatory approval. Barclays analysts said last month they expect the treatment could generate roughly $3 billion in melanoma-related revenue by 2035, underscoring the scale of the opportunity Wednesday’s trial results could unlock for Moderna specifically, given the company’s smaller existing revenue base compared with Merck’s broader portfolio.

Wednesday’s announcement arrives as Moderna has worked to diversify its business well beyond the COVID-19 vaccine that first made the company a household name. The company recently gained Food and Drug Administration approval for its flu vaccine, branded mFLUSIVA, targeted at adults 50 and older, marking its fifth approved global product. Moderna has also continued developing experimental vaccines for other conditions, including norovirus and Lyme disease, though the company disclosed that a key Phase 3 norovirus trial recently missed its early success criteria, a setback that stood in contrast to Wednesday’s positive melanoma vaccine news.

Melanoma remains the deadliest form of skin cancer, with more than 1.5 million cases diagnosed globally in 2023 alone, according to figures cited in coverage of the trial. The scale of that patient population, combined with the trial’s success in both its primary and key secondary endpoints, has fueled substantial investor optimism regarding the treatment’s eventual commercial prospects, even as the companies caution that a full data readout, including mature survival figures, and eventual regulatory review still lie ahead before the therapy could reach patients more broadly. As Wednesday’s trading session continued, market watchers were closely monitoring whether Moderna’s dramatic premarket gains would hold through the full trading day, given the stock’s history of significant volatility tied to individual clinical trial announcements throughout its post-pandemic transition toward a broader, more diversified product pipeline.

Yes. Corporate subscriptions are available for teams and organisations, with discounted rates as user numbers increase. Pricing starts from $1,625 + GST per user.
Get in touch
to discuss the right option for your organisation.

Business News subscriptions are used by executives, investors, consultants and professionals who need to stay informed and make better decisions about the WA market. When you subscribe you’ll get

• Unlimited access to WA’s most trusted business journalism
• Data & Insights — detailed profiles of WA companies, people, projects and deals
• MyBN — a personalised feed based on the companies, people and sectors you follow
• Special publications and industry reports
• Daily and weekly email newsletters

Data & Insights is a research tool built specifically for the WA market. It draws on more than 30 years of Business News reporting, updated regularly to reflect what’s happening now. Use it to:

• Look up detailed profiles of WA companies, including financials, directors and ownership
• Find decision-makers and track their career movements
• Research live and completed projects across WA industries
• Monitor deals, appointments and market activity
• Access industry rankings and league tables

Data & Insights is updated daily by our dedicated research team, which uses the latest announcements, ASX filings and editorial coverage to keep our person, company, list and project records up to date.

Business News welcome all opportunities to make our dataset accurate, complete and current, so if you have an update request, please email the team at
general@businessnews.com.au, and we’d be happy to assist.

MyBN
is part of every subscription. It’s your personalised view of Business News. You can follow the companies, people, sectors and projects that matter to you, and get a news feed and alerts tailored to your interests. You can save articles to read later and retain only what you need.

Only subscribers have full access to all content on the Business News website.

If staying informed about the WA economy is part of your job, and/or you’re looking for networking opportunities in WA, Business News is built for you.

Business News subscribers are:

• Executives and directors tracking competitors, clients and market movements
• Investors and advisers researching companies, deals and industry trends
• Consultants and professionals staying across sectors relevant to their clients
• Business owners looking for leads, context and market intelligence

Most Business News publications cover national or global markets. Business News is focused entirely on Western Australia, which means the journalism, the data and the intelligence are all built around WA companies, people and projects — not adapted from a national feed. Data & Insights, included with every subscription, combines more than 30 years of WA-specific editorial research with live business data. There’s no comparable product for the WA market.

The Morning Digest Email provides a comprehensive wrap of the major headlines, relevant to WA business, and includes with a snapshot of the overnight news covering oil, gold and ASX-listed companies.

The Afternoon Wrap Email focuses on the news covered by our team of journalists during the course of the working day, including exclusive stories and analysis, all of which relates to WA business and the local economy.

The BN Weekender Email contains a wrap of the Business News from the week that was, highlighting the top stories in each area of WA business.
Sign up for free.

We’re happy to help.
Get in touch
and our team will come back to you.

ChatGPT-maker OpenAI on Tuesday announced that it’s creating a new portal for teenagers between the ages of 13 and 17 as it looks to address concerns about online safety for young people.

The company made the announcement exclusively on-air with Fox News’ “Fox & Friends” on Tuesday morning and outlined how the platform looks to address the potential for the misuse of the platform by children.

The ChatGPT for Teens portal will serve as the default experience on the artificial intelligence (AI) chatbot for users between the ages of 13 and 17 and will come with new safeguards aimed at fostering the safe use of the platform and supporting teens’ critical thinking skills.

OpenAI said that most teen users of ChatGPT use it for homework and help with their studies, so the new platform is intended to allow for study aides without giving the answers away and was designed with Stanford University.

OPENAI UNVEILS CHATGPT WORK TO AUTOMATE WORKPLACE TASKS AS AI RACE INTENSIFIES

OpenAI’s new ChatGPT for Teens platform has safeguards tailored to ensuring the safety of young people using the platform. (Jaap Arriens/NurPhoto via Getty Images)

It will feature quizzes and responsible-homework reminders that redirect teens toward collaborative problem-solving, as well as a Study Hours feature that allows teens or parents to set Study Mode as a default during certain time periods.

The new platform includes stronger default safeguards addressing self-harm, violence, eating disorders, dangerous activities and explicit sexual or graphic content through age-appropriate interventions.

There will be teen-specific onboarding to the platform with warnings that discourage users from uploading private or sensitive images.

5 MOST EXPLOSIVE CLAIMS FROM FLORIDA’S LAWSUIT AGAINST OPENAI, SAM ALTMAN

OpenAI and CEO Sam Altman have faced calls to add more safeguards for children on the platform. (Anna Moneymaker/Getty Images)

It also looks to address parental concerns about teens forming an emotional dependency or relationship with new safeguards barring the use of language that could suggest romantic feelings, as well as claims of sentience of personal feelings by ChatGPT.

The platform will also restrict the chatbot from framing ChatGPT as being more important than family, friends, educators, mentors or other trusted people in the life of the tool’s teenage user.

The platform is also set to include default settings that provide more guardrails against the overuse of the program and healthier usage patterns.

OPENAI ROLLS OUT CHATGPT PARENTAL CONTROLS WITH HELP OF MENTAL HEALTH EXPERTS

OpenAI’s teen-oriented platform comes with default settings aimed at preventing the misuse of the tool. (Omar Marques/SOPA Images/LightRocket via Getty Images)

It will have default settings that encourage users to take breaks more frequently, along with reminders about the platform’s settings for Study Hours and Quiet Hours.

Additionally, the new platform will provide the user with cues to reinforce that ChatGPT is a tool and not a person or a replacement for human relationships.

The new safeguards for OpenAI’s ChatGPT for Teens platform following incidents in which teenage users turned to the platform during mental health crises.

GET FOX BUSINESS ON THE GO BY CLICKING HERE

Mark Walter, who already sold his majority stake in the Los Angeles Lakers just one year after purchasing the NBA team, might be selling off yet another sports asset. 

Walter and business partner Todd Boehly are reportedly looking to sell their stakes in Chelsea Football Club of the English Premier League, according to the Financial Times.

Walter and Boehly are hoping to sell their stakes to Clearlake Capital, the majority owner of one of the most popular soccer teams in the entire world. 

CLICK HERE FOR MORE SPORTS COVERAGE ON FOXBUSINESS.COM

Mark Walter, CEO of Guggenheim Partners, and Ilana Kloss attend day 13 of the French Open 2022 held at Stade Roland Garros on June 3, 2022, in Paris, France. (Jean Catuffe/Getty Images / Getty Images)

Clearlake Capital reportedly has had some friction with the two minority stakeholders after they purchased a piece of the club four years ago. The outlet reported there have been negotiation talks for years between both sides, but no deal was made. 

Walter and Boehly bought stakes in Chelsea in May 2022, as BlueCo, a consortium run by Boehly, and Clearlake Capital bought the club from Roman Abramovich. 

BUSS FAMILY AGREES TO SELL REMAINING LAKERS OWNERSHIP STAKE TO JOSH KUSHNER, BOB IGER GROUP

The news is quite interesting, though, as Walter agreed to sell the Lakers to Josh Kushner and Bob Iger for a record $12.5 billion after just purchasing the ownership stake from the Buss family for $10 billion last year. 

In June 2025, the Buss family decided to sell the Lakers to Walter for $10 billion. There was, however, some in the Buss family who felt misled by Jeanie Buss in what they characterized as a rushed sale, per ESPN. They felt pressured to vote for the sale to go through. 

Mark Walter of the Guggenheim Baseball Management group, applauds a speech by partner Earvin “Magic” Johnson at a press conference introducing them as new Dodgers owners in center field at Dodger Stadium. (Robert Gauthier/Los Angeles Times / Getty Images)

In the end, all six siblings said “yes” to the sale, which closed in October 2025. The sale gave each sibling $500 million post-tax. After the sale to Walter, Buss was allowed to remain the governor of the Lakers given the 17.8% ownership stake still intact. 

Word came out Monday that the Buss family is now looking to tack onto the deal with Kushner and Iger to sell their remaining shares in the NBA team, which would give the new ownership group a whopping 83% majority in one of the most iconic basketball franchises in the world. However, new reports indicate Jeanie was the only sibling that did not wish to relinquish ownership, and will be fighting the decision made, per multiple outlets. 

Walter’s surprise sale of the Lakers comes amid a federal investigation into the Guggenheim Partners CEO. It was reported that the FBI recently seized Walter’s phone and laptop, as well as a high-ranking Guggenheim Investments executive’s this past year. 

Some are viewing the Lakers’ sale as a quick way to liquify assets for Walter with potential legal problems ahead, and now Chelsea could be yet another way to do so. 

Mark Walter, owner and chairman, Los Angeles Dodgers speaks during the unveiling ceremony of a brand new Koufax commemorative statue at the Centerfield Plaza at Dodger Stadium. (Jayne Kamin-Oncea-USA TODAY Sports / IMAGN)

GET FOX BUSINESS ON THE GO BY CLICKING HERE

Chelsea was sold to the group for a total 2.5 billion pounds back in 2022. An extra 1.75 billion pounds was committed for future investment in the signature Stamford Bridge stadium, the Chelsea academy, the women’s team and the Chelsea Foundation. 

The current valuation of Chelsea is estimated to be around 5 billion pounds.

Follow Fox News Digital’s sports coverage on X and subscribe to the Fox News Sports Huddle newsletter.

Naturewall, which has bases in Beverley and Leeds, makes wooden wall panels and has appeared on Channel 4’s Grand Designs and BBC’s DIY SOS

A Yorkshire firm that has graced the screens of both Grand Designs and DIY SOS is poised for expansion following a seven-figure funding agreement. Naturewall was founded in 2018 by Philip Brown and John Hallam, with the aim of helping homeowners and commercial clients revamp their spaces using nature-inspired wall panels.

Its timber wall panels are crafted at its workshops for use throughout the home, encompassing Victorian and Georgian style panels, waterproof shower panels, acoustic panels for sound absorption and slatted panels. The Beverley-based business, which also operates a base in Leeds, has grown to become the UK’s largest SlatWall manufacturer, bolstered by a thriving home improvement and interior décor sector.

Over the years, the company’s impressive wood panels have been used to enhance everything from gyms and salons to bathrooms and bedrooms, with its elegant designs also earning television appearances. The company has featured on Channel 4’s Grand Designs, as well as BBC’s DIY SOS, which joined forces with Naturewall to renovate the much-loved Cherry Tree Community Centre (CTCC) in Beverley, a local hub since 1993.

Now Naturewall, which employs 43 members of staff across its two Yorkshire locations, has secured an HSBC UK funding deal to bolster its stockholding capacity. Company bosses confirmed the investment will drive future growth ambitions by broadening and diversifying its panel range.

As part of its ongoing growth strategy, the firm has successfully broadened its retail partnerships throughout the UK, including an exclusive Made in Britain supply agreement with one of the country’s largest national kitchen, bedroom and bathroom retailers. With capacity bolstered by HSBC UK funding, Naturewall’s leadership team is forecasting a 30 per cent rise in turnover over the next 12 months, reports Hull Live.

Philip Brown, managing director of Naturewall, said: “Securing funding and increasing our working capital flexibility is an important milestone for the business. The steps we are taking today strengthen our ability to deliver new innovations in products, while scaling the availability of our products for customers and ensuring consistent standards of service.”

Becky Young, relationship manager at HSBC UK, added: “It’s fantastic to support Naturewall achieve this ambitious phase of growth. As the business expands its product portfolio and stock holding capabilities, it will continue to develop as a leading Made in Britain UK accredited manufacturer. We look forward to seeing how this funding supports the future success of the business in the UK and overseas.”

The HSBC UK-funded acquisition was facilitated through an introduction by Chris Mangle, director at Custom Business Finance.